Certified by Founder Lodge
ArteraAI
United States - Los Altos, California
START UP
1 Disclosed Funding Rounds $90,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.
Five Phase III randomized trials were used to develop prognostic and predictive AI biomarker
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 27 ,2023 | Unknown | $90,000,000 | |
| February, 02 ,2024 | Unknown | $20,000,000.00 |
Rill Data
Google
Salesforce.org
Coatue
Koch Disruptive Technologies
Johnson & Johnson
Walden Catalyst Ventures
Breyer Capital
Factory
Hazel Health
LA Clippers
Stanford University
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)